Abstract
The inhibitor cystine knot (ICK) is an unusual three-disulfide architecture in which one of the disulfide bonds bisects a loop formed by the two other disulfide bridges and the intervening sections of the protein backbone. Peptides containing an ICK motif are frequently considered to have high levels of thermal, chemical and enzymatic stability due to cross-bracing provided by the disulfide bonds. Experimental studies supporting this contention are rare, in particular for spider-venom toxins, which represent the largest diversity of ICK peptides. We used ω-hexatoxin-Hv1a (Hv1a), an insecticidal toxin from the deadly Australian funnel-web spider, as a model system to examine the contribution of the cystine knot to the stability of ICK peptides. We show that Hv1a is highly stable when subjected to temperatures up to 75 °C, pH values as low as 1, and various organic solvents. Moreover, Hv1a was highly resistant to digestion by proteinase K and when incubated in insect hemolymph and human plasma. We demonstrate that the ICK motif is essential for the remarkable stability of Hv1a, with the peptide’s stability being dramatically reduced when the disulfide bonds are eliminated. Thus, this study demonstrates that the ICK motif significantly enhances the chemical and thermal stability of spider-venom peptides and provides them with a high level of protease resistance. This study also provides guidance to the conditions under which Hv1a could be stored and deployed as a bioinsecticide.
Keywords: inhibitor cystine knot, physicochemical stability, spider toxin, insecticidal toxin, ω-hexatoxin-Hv1a, thermal stability, proteolytic degradation
1. Introduction
The inhibitor cystine knot (ICK) is a protein scaffold defined as an antiparallel β sheet stabilized by a cystine knot [1,2]. The β sheet typically comprises two β strands, although a third N-terminal strand is sometimes present [3] (Figure 1A). The cystine knot itself comprises a ring formed by two disulfide bridges (Cys1–Cys4 and Cys2–Cys5) and the intervening sections of peptide backbone, with a third disulfide bond (Cys3–Cys6) penetrating the ring to create a pseudo-knot (Figure 1B). The two central disulfide bridges emanating from the β strands are tightly packed against one another and they form the compact hydrophobic core of ICK peptides [4].
Peptides containing an ICK motif are found in taxonomically diverse organisms ranging from fungi and plants to molluscs and arthropods [1,7], although they are most abundant in the venom of spiders [8]. ICK-containing peptides are frequently considered to be highly stable over a wide range of physicochemical conditions, but very few studies have experimentally examined their stability. The best-studied example is kalata B1, a plant cyclotide whose thermal, chemical and enzymatic stability has been examined in detail. Remarkably, it was demonstrated that the cystine knot is more important for the stability of this cyclic peptide than its circular backbone [9].
The ICK motif is the most common protein architecture found in spider-venom peptides [8], but data on the contribution of this motif to the stability of spider toxins is lacking. Thus, in the present study, we used the insecticidal spider-venom peptide ω-hexatoxin-Hv1a (Hv1a) as a model ICK peptide and explored the contribution of the cystine knot to its physicochemical stability. Hv1a is 37-residue ICK peptide isolated from the venom of the lethal Australian funnel-web spider Hadronyche versuta (Figure 1C). It has been used as a lead for bioinsecticide development due to its ability to selectively block invertebrate, but not vertebrate, voltage-gated calcium (CaV) channels [5,8,10,11,12] and its lack of toxicity to bees [13]. Hv1a has high level of biological stability as it is active when expressed in planta [8,14] and it is capable of crossing the insect blood brain barrier in order to inhibit CaV channels in the insect central nervous system [5,15]. The molecular basis of Hv1a’s inherent biological stability is presumed to be its ICK motif but this has not been experimentally demonstrated.
In order to determine how the cystine knot contributes to the physicochemical stability of Hv1a, we compared native Hv1a with reduced and alkylated (linear) Hv1a over a wide range of temperatures, solvents and pH conditions, and after incubation in proteinase K, insect hemolymph, and human plasma. We show that Hv1a has a high level of chemical and thermal stability and that it is highly resistant to proteolytic degradation. Reduction and alkylation of the six cysteine residues that form the cystine knot motif of Hv1a completely abrogated the peptide’s resistance to enzymatic degradation and its resistance to high temperature and acidic pH. Even the long-term stability of Hv1a in water and organic solvents was compromised by loss of the ICK motif. This study reveals that the ICK motif is capable of providing spider-venom peptides with a high level of thermal, chemical and biological stability, and it further highlights the ICK motif as an excellent scaffold for protein engineering studies directed towards the development of peptide drugs and bioinsecticides.
2. Results and Discussion
2.1. Thermal Stability
Figure 2 summarises the stability of Hv1a when incubated for 24 h over a temperature range from 20 to 95 °C. There was no visible effect on toxin stability for both native and linear Hv1a up to 37 °C (Figure 2), but peptide stability decreased at a much faster rate for linear Hv1a at temperatures exceeding 37 °C. Remarkably, ~71% of native Hv1a remained intact after incubation for 24 h at 75 °C, whereas only ~25% of linear Hv1a remained intact under these conditions. In order to determine whether the degradation observed at high temperature is reversible, we incubated a sample of Hv1a at 95 °C for 24 h, then stored the sample at 20 °C for 3 days prior to HPLC analysis. There was no recovery in the level of intact peptide over the 3 days (data not shown), indicating that the degradation observed at 95 °C is irreversible. Nevertheless, based on the data shown in Figure 2, Hv1a should be highly stable in the field even if employed as a bioinsecticide in climates that reach high temperatures.
2.2. pH Stability
Figure 3 shows the stability of Hv1a when incubated for 24 h in buffers with pH ranging from 1 to 13. Native Hv1a was highly stable at neutral and acidic pH, with essentially no degradation between pH 1 and 7. However, the peptide began to degrade as the pH approached the pKa of cysteine (~8.3), and degradation became very apparent at pH 9 and above. Only 6% of the peptide remained intact after 24 h at pH 13 (Figure 3). Additional peaks with higher retention time than Hv1a began to emerge in the RP-HPLC chromatograms of samples incubated at pH 8 and higher (data not shown). MALDI mass spectrometric analysis revealed that these peaks have the same mass as Hv1a and we therefore conclude that these peaks correspond to isoforms of Hv1a resulting from disulfide-bond shuffling at alkaline pH. In contrast with native toxin, the linear version of Hv1a was only stable at neutral pH values, with marked degradation under both acidic and alkaline conditions. This instability presumably arises from well-known processes that impact on protein stability such as asparagine deamidation, aspartate isomerisation, and racemisation [16,17]. Interestingly, Hv1a contains an Asn-Gly sequence (Figure 1), which has been shown to be highly susceptible to asparagine deamidation [18].
The pH of the gut lumen in insects is highly variable, although there is a general trend, particularly in exopterygous insects, towards acidic crops, neutral to mildly alkaline midguts, and neutral to acidic hindguts [19,20]. Hv1a is stable under all of these pH conditions. However, several orders of endopterygote insects such as lepidopterans, coleopterans, and dipterans have highly alkaline midguts (pH > 8) [19,20,21]. This is especially true of lepidopteran larvae that feed on the leaves of trees, where the average midgut pH of ~8.7 is believed to provide protection against leaf tannins and two-component plant chemical defenses [21,22]. The instability of Hv1a at pH > 8 may therefore compromise its effectiveness against lepidopterans and other insects with highly alkaline guts. Nevertheless, it has been shown that transgenic expression of Hv1a in tobacco and cotton provides high levels of resistance against larvae of the lepidopterans Helicoverpa armigera (cotton bollworms) and Spodoptera littoralis (cotton leafworms) [23,24,25]. Thus, Hv1a must be sufficiently stable within the gut of these lepidopterans that enough toxin is taken up into the hemolymph to cause toxic effects at target sites (i.e., CaV channels) within the central nervous system.
2.3. Chemical Stability
Figure 4 shows that native Hv1a is highly stable during long-term incubation at room temperature (in the dark) in water and different organic solvents (i.e., ethanol, methanol and acetonitrile). In contrast, linear Hv1a was unstable over one week in water and all three organic solvents, although stability was marginally higher in acetonitrile. This further highlights the importance of the cystine knot for the long-term stability of ICK peptides. The long-term stability of Hv1a in organic solvents is useful from a bioinsecticide development perspective since insecticides are often formulated with emulsifiers, stabilisers, surfactants or other adjuvants that require dissolution in organic solvents [26].
2.4. Proteolytic Stability
Proteinase K is a broad-spectrum serine protease from the fungus Engyodontium album that primarily cleaves at peptide bonds on the C-terminal side of aliphatic and aromatic amino acid residues. It is commonly used to remove contaminating protein from nucleic acid preparations [27], and consequently it provides a stringent test of peptide/protein stability. Hv1a is predicted to contain 10 proteinase K cleavage sites dispersed along the entire length of the toxin (see Figure 1C). Thus, as expected, linear Hv1a was highly susceptible to proteinase K cleavage, with less than 25% of the peptide remaining intact after incubation for just 2 h at 37 °C using a 1:200 molar ratio of proteinase K:Hv1a (Figure 5, grey squares). In striking contrast, 74% of native Hv1a remained intact after incubation for 24 h under the same conditions (Figure 5, black circles). Thus, the ICK motif of Hv1a provides a very high level of resistance against the proteolytic activity of proteinase K.
2.5. Stability in Insect Hemolymph
Since Hv1a is considered a lead peptide for bioinsecticide development [8,13], its stability in insect gut and hemolymph is critical in addition to its environmental stability. We therefore examined the stability of Hv1a in hemolymph extracted from sawfly larvae and cotton bollworms (i.e., larvae of the recalcitrant lepidopteran pest Helicoverpa armigera). Most insects carefully regulate the pH of their hemolymph, typically in the range 6.4–6.8 [19,28,29]. The pH of the extracted sawfly hemolymph was measured to be 6.68, which is similar to the pH of 6.99 reported for hemolymph from larvae of the European pine sawfly Neodiprion sertifer [30]. The hemolymph extracted from H. armigera larvae had a pH of 6.45, which is slightly lower than the pH of 6.8 reported for hemolymph from larvae of the related lepidopteran H. zea [31]. Although native Hv1a is highly stable at neutral and acidic pH (see Figure 3), insect hemolymph contains proteases that can degrade exogenous peptides [32]. Nevertheless, we found that Hv1a is highly stable in insect hemolymph, with 54%–68% of the peptide remaining intact after seven days incubation at ambient temperature (~20 °C) in hemolymph from sawfly larvae (Figure 6A) and bollworms (Figure 6B). In contrast, only 11%–25% of linear Hv1a remained intact after one day of incubation with sawfly or bollworm hemolymph (Figure 6A,B, grey squares), again highlighting the importance of the cystine knot for providing resistance against chemical degradation and proteases.
Unfortunately, we were unable examine toxin stability in insect midgut solution, as we found it difficult to isolate midgut contents without contamination from foregut, hindgut or hemolymph.
2.6. Stability in Human Plasma
Remarkably, we found that Hv1a is even more stable in human plasma than insect hemolymph, with ~70% of the peptide remaining intact after seven days incubation in plasma at ~20 °C (Figure 7, black circles). In contrast, only ~7% of linear Hv1a remained intact after three days incubation in human plasma (Figure 7, grey squares). Thus, the cystine knot of Hv1a provides exceptional resistance against plasma proteases as well as plasma reductants such as glutathione and serum albumin that can potentially reduce disulfides add/or cause disulfide scrambling [33].
2.7. Comparison of Hv1a Stability with Other ICK Peptides
The ICK motif is an unusual protein architecture in which a single disulfide bond is threaded through a closed loop formed by two other disulfide bonds and the intervening sections of the polypeptide backbone [1,3,7,34]. ICK peptides, also known as knottins [34], have evolved independently in a diverse range of terrestrial taxa, including insects, arachnids, fungi, and plants [7], as well as marine cone snails [1], sponges [35], horseshoe crabs [36] and sea anemones [37]. This protein fold appears to have been evolutionarily favoured for two reasons. First, the ICK motif is highly plastic to sequence changes [38,39], which allows it to support a wide variety of disparate functions [7]. Second, although it is not a true knot in the mathematical sense, the inhibitor cystine knot is expected to greatly reduce the propensity for peptide unfolding, and hence it is generally thought to imbue ICK peptides with a high level of physicochemical stability [4,7,40].
Surprisingly, very few studies have examined the stability of native knottin peptides in detail, much less addressed whether the cystine-knot motif is the underlying cause of unusually high levels of chemical, thermal and biological stability. The only systematic study of this kind was performed on kalata B1, a plant cyclotide [9]. Cyclotides are macrocyclic plant knottins containing a head-to-tail cyclised peptide backbone in addition to a cystine knot motif. Kalata B1 was shown to be highly thermostable and extremely resistant to chaotropic agents and proteases. These properties were largely retained in an acyclic permutant but not when the disulfide bonds were eliminated by reduction and alkylation, which led the authors to conclude that the cystine knot, rather than backbone cyclization, is the primary contributor to the remarkable stability of kalata B1 [9]. The same authors demonstrated that native conotoxin PVIIA, a knottin peptide from the venom of a marine cone snail, is impervious to various endoproteinases but this protease resistance is lost when the cystine knot is eliminated by disulfide reduction [9]. Engineered ICK peptides derived from plant knottins or the cystine-knot motif of human agouti-related protein were shown to be highly resistant to pepsin and elastase, and have long half-lives in rat plasma, but the contribution of the cystine knot to these properties was not examined [41,42]. A variety of diverse ICK peptides from sponges [35] and spiders [32] have been shown to be resistant to proteases and/or have high levels of stability in human plasma or insect hemolymph, but the contribution of the cystine-knot motif to this stability was not examined.
The current work represents the first systematic study of the contribution of the inhibitor cystine knot to the thermal, chemical, and biological stability of a native, non-cyclic knottin. We demonstrated that the cystine knot underlies the remarkable resistance of the insecticidal toxin Hv1a to extremes of temperature, acidic pH, organic solvents, and both human plasma and insect hemolymph. Highly alkaline pH (>8) was the only condition under which native Hv1a was not considerably more stable than its linearised counterpart, presumably due to reduction/scrambling of the disulfide bonds in the cystine knot as the pH exceeds the pKa of the cysteine side-chain thiol groups. OAIP-1, an insecticidal knottin from tarantula venom, was also found to be susceptible to degradation under alkaline conditions [32].
Hv1a was isolated from the venom of the Australian funnel-web spider Hadronyche versuta, a close relative of the infamous Sydney funnel-web spider Atrax robustus that is lethal to rodents and primates [43]. The lethal component of A. robustus venom is the knottin peptide δ-hexatoxin-Ar1a [44,45,46], which potently delays inactivation of voltage-gated sodium channels [47]. Thus, data from 1961 on the stability of crude A. robustus venom [43] can be considered a proxy for the stability of δ-hexatoxin-Ar1a. Wiener found that the toxicity to mice of A. robustus venom was not altered after storage for four months at 4 °C, incubation at 37 °C for two days, incubation at 100 °C for 1 h, incubation at 100 °C for 20 min in the presence of 0.1 M HCl (pH~1), storage for 14 days in 33% acetic acid, and incubation with 0.1% pepsin and 0.2% HCl at 40 °C for 2 h [43]. However, incubation of venom for 24 h at pH 8.5 and 37 °C resulted in a slight loss of activity, incubation for 2 h at 40 °C with 0.1% trypsin and 0.1% Na2CO3 (pH ~11) resulted in a 50% loss of toxicity, and activity was completely lost when venom was incubated with 0.1 M NaOH (pH~13) for 20 min at 100 °C [43]. Finally, Wiener found that although A. robustus venom precipitates in 80% ethanol, the precipitate readily dissolves in water and retains toxicity [43]. Thus, A. robustus venom, and by extension the lethal knottin peptide δ-hexatoxin-Ar1a, is stable under the same conditions as Hv1a: it is resistant to extremes of temperature, acidic pH, ethanol, and proteases, but is susceptible to degradation under highly alkaline conditions. We conclude that these are likely to be general properties of spider-venom knottins.
3. Experimental Section
3.1. Chemicals
2-Aminoethanol and triethylphosphine were from Sigma-Aldrich (Castle Hill, NSW, Australia). 2-Iodoethanol was from Acros Organics (Thermo Fisher Scientific, Geel, Belgium). Proteinase K was from Promega (Madison, WI, USA) and synthetic Hv1a was kindly supplied by Vestaron Corporation (Kalamazoo, MI, USA).
3.2. Sample Treatment
Every condition for each treatment was tested in triplicate for both native and linear Hv1a, and all data reported are mean ± SD. Unless otherwise stated, all samples were immediately frozen after treatment and then analysed via HPLC. Native Hv1a was linearised by one-step reduction and alkylation (RA) of the six Cys residues [48]. Toxin (1 mg) was dissolved in 450 µL of water prior to addition of 5 µL aminoethanol, 10 µL iodoethanol, 2 µL triethylphosphine (0.1 M solution in tetrahydrofuran), and 450 µL acetonitrile. After incubation at 37 °C for 2 h, the toxin sample was dried by vacuum centrifugation and the fully reduced and alkylated toxin was purified using RP-HPLC on a Shimadzu 20A series HPLC system (Shimadzu Scientific Instruments, Rydalmere, NSW, Australia).
All native Hv1a samples were processed using a reverse-phase analytical column (Jupiter C18, 5 µm particle size, 300 Å pore size, 150 × 4.6 mm; Phenomenex, Lane Cove, NSW, Australia;) on a Shimadzu 20A series HPLC system, with detection at 214 nm. Solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in 90% acetonitrile) were used at a flow rate of 1 mL/min using a gradient of 5% solvent B for the first 3 min, 5%–25% solvent B over the next 10 min, then 25%–80% solvent B over 0.5 min. For all linear Hv1a samples, a VisionHT HILIC column (5 µm particle size, 150 × 4.6 mm; Grace, Columbia, MD, USA) was used on a Shimadzu 20A series HPLC system with HILIC-solvent A (0.05% triflouracetic acid (TFA) in water) and HILIC-solvent B (90% acetonitrile, 0.043% TFA in water). The following gradients were used for the HILIC runs: 85% HILIC solvent B for the first 3 min, then 85%–55% HILIC solvent B for another 6 min, then 55%–5% HILIC solvent B for 1 min followed by 5% HILIC solvent B for 1 min. Peptide peaks (identified from absorbance at 214 nm) were collected manually and molecular masses determined using MALDI mass spectrometry on a 4700 Proteomics Analyzer (Applied Biosystems, Foster City, CA, USA) using α-cyano-4-hydroxycinnamic acid (CHCA) as matrix. The fractions containing native or linear Hv1a were identified based on molecular mass and retention time, then the amount of intact toxin after each treatment was quantified based on peak area.
3.3. Thermal Stability
Thermal stability was examined by incubating native (24.7 µM) and linear Hv1a (18.7 µM) for 24 h at various temperatures (20, 37, 50, 75 and 95 °C). Following the respective incubation period, samples were immediately stored at −20 °C prior to HPLC fractionation. In order to determine whether the effect of high temperature is reversible for the native Hv1a, a sample was incubated for 24 h at 95 °C and then stored at room temperature for three days before HPLC analysis. All native and linear Hv1a amounts were quantified relative to their respective 20 °C sample.
3.4. pH Stability
Stability under varying pH conditions was assessed by incubating native (49.4 µM) and linear Hv1a (18.7 µM) for 24 h at room temperature in buffers of the following pH/composition (pKa values for the relevant species are indicated): (i) pH 1 (50 parts 0.2 M KCl plus 134 parts 0.2 M HCl); (ii) pH 4 (0.2 M sodium acetate, pKa 4.76); (iii) pH 7 (100 parts 0.1 M KH2PO4 plus 58.2 parts 0.1 M NaOH; pKa2 7.21); (iv) pH 8 (100 parts 0.1 KH2PO4 plus 93.4 parts 0.1 M NaOH; pKa2 7.21); (v) pH 9 (0.1 M Tris-HCl, pKa 8.07); (vi) pH 10 (966.4 parts 0.1 M Na2HPO4 plus 33.6 parts 0.1 M NaOH); (vii) pH 13 (50 parts 0.2 M KCl plus 132 parts 0.2 M NaOH). After the incubation period, native Hv1a samples were desalted using a Maxi-Clean SPE column (Large Pore C18; Grace, Columbia, MD, USA) before application onto the C18 HPLC column. For desalting, 10 mL of 5% solvent B was used to remove salts then Hv1a was eluted with 10 mL of 45% solvent B and lyophilised prior to RP-HPLC analysis. All native and linear Hv1a amounts were quantified relative to their respective pH 7 sample.
3.5. Chemical Stability
The long-term stability of native (49.4 µM) and linear Hv1a (18.5 µM) in water and organic solvents was determined by incubation in Milli-Q water, methanol, ethanol or acetonitrile in the dark for seven days at room temperature. All samples were then lyophilised before HPLC analysis. The amounts of native and linear Hv1a were quantified relative to a respective control sample that was incubated in Milli-Q water for one day.
3.6. Proteolytic Stability
Analysis of the Hv1a sequence using PeptideCutter [6] indicated that it contains more potential cleavage sites for proteinase K than any other protease examined (Figure 1C). Accordingly, native Hv1a (24.7 µM) was incubated in a pH 7.5 buffer (0.2 M phosphate, 5 mM CaCl2) with proteinase K added at a molar ratio of 1:200 (proteinase K:Hv1a). Samples were then incubated at 37 °C for 24 h. An identical sample of native Hv1a without proteinase K was used as a negative control and also incubated at 37 °C for 24 h. This sample was used as a reference (i.e., set to 100%) for the relative quantification of native Hv1a sample incubated in the presence of proteinase K. After the incubation period, native Hv1a samples were processed through a Maxi-Clean C18 column prior to HPLC (conditions see above under pH stability). Linear Hv1a (6.9 µM) was incubated in a pH 7.5 buffer (0.2 M phosphate, 5 mM CaCl2) with proteinase K added at a molar ratio of 1:200 (proteinase K:Hv1a) for a range of different time intervals (20 and 40 min, and 1, 2, 5, 8 and 24 h). All linear Hv1a amounts were quantified relative to a sample of linear Hv1a in the pH 7.5 buffer (without proteinase K) that was immediately processed through a Maxi-Clean C18 column prior to HPLC. All other samples were incubated for the respective incubation time before being cleaned through a Maxi-Clean C18 column.
3.7. Stability in Insect Hemolymph
Sawfly larvae (Hymenoptera, Pergidae) were collected from Regency Downs, Queensland, Australia. Fifth instar H. armigera larvae were purchased from AgBiTech Pty Ltd. (Clifford Gardens, Queensland, Australia). A 1.0 mL Terumo Insulin syringe (B-D Ultra-Fine, Terumo Medical Corporation, Somerset, NJ, USA) with a fixed 29 gauge needle was used to puncture the insect exoskeleton and collect the extruded hemolymph, which was then centrifuged at 4 °C for 10 min at 10,000 rpm to remove insoluble material. The pH of supernatant was measured using an Ultra M Micro Combination pH electrode (Van London Co., Houston, TX, USA). Native Hv1a (367 µM) and linear Hv1a (154 µM) were dissolved in clarified hemolymph, then the samples were incubated for 1–7 days at room temperature (~20 °C). Prior to HPLC analysis, all samples were processed through a Maxi-Clean SPE column. A HPLC chromatogram of a hemolymph-only control sample was subtracted from each HPLC chromatogram of the respective native or linear Hv1a samples in order to account for peaks originating from endogenous hemolymph compounds. All native and linear Hv1a amounts were quantified relative to a respective control sample that was incubated in Milli-Q water for one day.
3.8. Stability in Human Plasma
Native Hv1a (367 µM) or linear Hv1a (116 µM) were incubated for 1–7 days at room temperature (~20 °C) in pooled human plasma (Innovative Research, Novi, MI, USA). Native and linear Hv1a samples incubated in Milli-Q water for seven days at room temperature (~20 °C) were used as controls. Prior to HPLC analysis, samples were processed through a Maxi-Clean SPE column. Native and linear Hv1a were quantified relative to a respective control sample that was incubated in Milli-Q water for one day.
3.9. Statistical Analyses
GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA) was used to determine statistically significant differences between native and linear Hv1a for each treatment condition using multiple t tests followed by a Holm-Sidak correction. p < 0.05 was defined as statistically significant.
4. Conclusions
We demonstrated that the insecticidal spider-venom peptide Hv1a is remarkably resistant to chemical degradation; the peptide is stable over the pH range 1–8, at temperatures up to 75 °C, and when dissolved in a range of organic solvents. Moreover, we found that Hv1a is highly resistant to proteolytic degradation, with outstanding stability in insect hemolymph and human plasma, and when incubated with proteinase K. These high levels of chemical and proteolytic resistance were completely abolished when the toxin’s ICK motif was destroyed by reduction and alkylation of the six cysteine residues. We conclude that the ICK motif, which is prevalent in spider-venom peptides, provides these toxins with remarkable levels of chemical, thermal, and biological stability.
The current study also provides a guide to the range of conditions under which Hv1a could be formulated and used as a bioinsecticide. Our data show that formulations requiring dissolution in organic solvents and/or acidic conditions should not adversely affect the stability of Hv1a. Moreover, we demonstrated that Hv1a has a high level of thermal stability, which should facilitate its application in the field in high-temperature climates.
Acknowledgments
The authors thank Vestaron Corporation for kindly supplying the Hv1a used in this study. This work was supported by Discovery Grant DP0878450 from the Australian Research Council.
Author Contributions
Volker Herzig and Glenn King conceived and designed the experiments; Volker Herzig performed the experiments and analyzed the data; Volker Herzig and Glenn King wrote the paper.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Pallaghy P.K., Nielsen K.J., Craik D.J., Norton R.S. A common structural motif incorporating a cystine knot and a triple-stranded β-sheet in toxic and inhibitory polypeptides. Protein Sci. 1994;3:1833–1839. doi: 10.1002/pro.5560031022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Norton R.S., Pallaghy P.K. The cystine knot structure of ion channel toxins and related polypeptides. Toxicon. 1998;36:1573–1583. doi: 10.1016/S0041-0101(98)00149-4. [DOI] [PubMed] [Google Scholar]
- 3.King G.F., Tedford H.W., Maggio F. Structure and function of insecticidal neurotoxins from Australian funnel-web spiders. J. Toxicol.-Toxin Rev. 2002;21:359–389. doi: 10.1081/TXR-120014409. [DOI] [Google Scholar]
- 4.Saez N.J., Senff S., Jensen J.E., Er S.Y., Herzig V., Rash L.D., King G.F. Spider-venom peptides as therapeutics. Toxins. 2010;2:2851–2871. doi: 10.3390/toxins2122851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fletcher J.I., Smith R., O’Donoghue S.I., Nilges M., Connor M., Howden M.E., Christie M.J., King G.F. The structure of a novel insecticidal neurotoxin, ω-atracotoxin-HV1, from the venom of an Australian funnel web spider. Nat. Struct. Biol. 1997;4:559–566. doi: 10.1038/nsb0797-559. [DOI] [PubMed] [Google Scholar]
- 6.PeptideCutter. [(accessed on 23 October 2015)]. Available online: http://web.expasy.org/peptide_cutter.
- 7.Craik D.J., Daly N.L., Waine C. The cystine knot motif in toxins and implications for drug design. Toxicon. 2001;39:43–60. doi: 10.1016/S0041-0101(00)00160-4. [DOI] [PubMed] [Google Scholar]
- 8.King G.F., Hardy M.C. Spider-venom peptides: Structure, pharmacology, and potential for control of insect pests. Annu. Rev. Entomol. 2013;58:475–496. doi: 10.1146/annurev-ento-120811-153650. [DOI] [PubMed] [Google Scholar]
- 9.Colgrave M.L., Craik D.J. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: The importance of the cyclic cystine knot. Biochemistry. 2004;43:5965–5975. doi: 10.1021/bi049711q. [DOI] [PubMed] [Google Scholar]
- 10.Tedford H.W., Gilles N., Ménez A., Doering C.J., Zamponi G.W., King G.F. Scanning mutagenesis of ω-atracotoxin-Hv1a reveals a spatially restricted epitope that confers selective activity against invertebrate calcium channels. J. Biol. Chem. 2004;279:44133–44140. doi: 10.1074/jbc.M404006200. [DOI] [PubMed] [Google Scholar]
- 11.Tedford H.W., Sollod B.L., Maggio F., King G.F. Australian funnel-web spiders: Master insecticide chemists. Toxicon. 2004;43:601–618. doi: 10.1016/j.toxicon.2004.02.010. [DOI] [PubMed] [Google Scholar]
- 12.Windley M.J., Herzig V., Dziemborowicz S.A., Hardy M.C., King G.F., Nicholson G.M. Spider-venom peptides as bioinsecticides. Toxins. 2012;4:191–227. doi: 10.3390/toxins4030191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Nakasu E.Y., Williamson S.M., Edwards M.G., Fitches E.C., Gatehouse J.A., Wright G.A., Gatehouse A.M. Novel biopesticide based on a spider venom peptide shows no adverse effects on honeybees. Proc. R. Soc. B. 2014;281:1–9. doi: 10.1098/rspb.2014.0619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bonning B.C., Pal N., Liu S., Wang Z., Sivakumar S., Dixon P.M., King G.F., Miller W.A. Toxin delivery by the coat protein of an aphid-vectored plant virus provides plant resistance to aphids. Nat. Biotechnol. 2014;32:102–105. doi: 10.1038/nbt.2753. [DOI] [PubMed] [Google Scholar]
- 15.Bloomquist J.R. Mode of action of atracotoxin at central and peripheral synapses of insects. Invertebr. Neurosci. 2003;5:45–50. doi: 10.1007/s10158-003-0027-z. [DOI] [PubMed] [Google Scholar]
- 16.Manning M.C., Chou D.K., Murphy B.M., Payne R.W., Katayama D.S. Stability of protein pharmaceuticals: An update. Pharm. Res. 2010;27:544–575. doi: 10.1007/s11095-009-0045-6. [DOI] [PubMed] [Google Scholar]
- 17.Furman J.L., Chiu M., Hunter M.J. Early engineering approaches to improve peptide developability and manufacturability. AAPS J. 2015;17:111–120. doi: 10.1208/s12248-014-9681-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Robinson N.E. Protein deamidation. Proc. Natl. Acad. Sci. USA. 2002;99:5283–5288. doi: 10.1073/pnas.082102799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Harrison J.F. Insect acid-base physiology. Annu. Rev. Entomol. 2001;46:221–250. doi: 10.1146/annurev.ento.46.1.221. [DOI] [PubMed] [Google Scholar]
- 20.Nation J.L. Insect Physiology and Biochemistry. 2nd ed. CRC Press; Boca Raton, FL, USA: 2008. [Google Scholar]
- 21.Berenbaum M.R. Adaptive significance of midgut pH in larval Lepidoptera. Am. Nat. 1980;115:138–146. doi: 10.1086/283551. [DOI] [Google Scholar]
- 22.Pentzold S., Zagrobelny M., Roelsgaard P.S., Moller B.L., Bak S. The multiple strategies of an insect herbivore to overcome plant cyanogenic glucoside defence. PLoS One. 2014;9 doi: 10.1371/journal.pone.0091337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Khan S.A., Zafar Y., Briddon R.W., Malik K.A., Mukhtar Z. Spider venom toxin protects plants from insect attack. Transgenic Res. 2006;15:349–357. doi: 10.1007/s11248-006-0007-2. [DOI] [PubMed] [Google Scholar]
- 24.Shah A.D., Ahmed M., Mukhtar Z., Khan S.A., Habib I., Malik Z.A., Mansoor S., Saeed N.A. Spider toxin (Hvt) gene cloned under phloem specific RSs1 and RolC promoters provides resistance against American bollworm (Heliothis armigera) Biotechnol. Lett. 2011;33:1457–1463. doi: 10.1007/s10529-011-0572-1. [DOI] [PubMed] [Google Scholar]
- 25.Omar A., Ali Chatha K. National Institute for Biotechnology and Genetic Engineering (NIBGE): Genetically modified spider cotton. Asian J. Manag. Cases. 2012;9:33–58. doi: 10.1177/097282011100900105. [DOI] [Google Scholar]
- 26.Foy C.L., Pritchard D.W. Pesticide Formulation and Adjuvant Technology. CRC Press; Boca Raton, FL, USA: 1996. [Google Scholar]
- 27.Strauss W.M. UNIT 2.2 Preparation of genomic DNA from mammalian tissue. Curr. Protoc. Mol. Biol. 2001 doi: 10.1002/0471142727.mb0202s42. [DOI] [PubMed] [Google Scholar]
- 28.Chapman R.F. The Insects: Structure and Function. 5th ed. Cambridge University Press; Cambridge, UK: 1998. [Google Scholar]
- 29.Kanost M.R. Hemolymph. In: Resh V.H., Cardé R.T., editors. Encylopedia of Insects. 2nd ed. Academic Press; Burlington, MA, USA: 2009. pp. 446–448. [Google Scholar]
- 30.Brown S.E., Patton R.L., Zerillo R.T., Douglas S.M., Breillatt J.P., Mazzone H.M. Comparative properties of hemolymph of the Gypsy moth and the European pine sawfly. J. N.Y. Entomol. Soc. 1977;85:36–42. [Google Scholar]
- 31.Wang Z., Haunerland N.H. Storage protein uptake in Helicoverpa zea. purification of the very high density lipoprotein receptor from perivisceral fat body. J. Biol. Chem. 1993;268:16673–16678. [PubMed] [Google Scholar]
- 32.Hardy M.C., Daly N.L., Mobli M., Morales R.A., King G.F. Isolation of an orally active insecticidal toxin from the venom of an Australian tarantula. PLoS One. 2013;8 doi: 10.1371/journal.pone.0073136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Armishaw C.J., Daly N.L., Nevin S.T., Adams D.J., Craik D.J., Alewood P.F. α-Selenoconotoxins, a new class of potent α7 neuronal nicotinic receptor antagonists. J. Biol. Chem. 2006;281:14136–14143. doi: 10.1074/jbc.M512419200. [DOI] [PubMed] [Google Scholar]
- 34.Gracy J., Le-Nguyen D., Gelly J.C., Kaas Q., Heitz A., Chiche L. KNOTTIN: The knottin or inhibitor cystine knot scaffold in 2007. Nucleic Acids Res. 2008;36:D314–D319. doi: 10.1093/nar/gkm939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Li H., Su M., Hamann M.T., Bowling J.J., Kim H.S., Jung J.H. Solution structure of a sponge-derived cystine knot peptide and its notable stability. J. Nat. Prod. 2014;77:304–310. doi: 10.1021/np400899a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Fujitani N., Kouno T., Nakahara T., Takaya K., Osaki T., Kawabata S., Mizuguchi M., Aizawa T., Demura M., Nishimura S., et al. The solution structure of horseshoe crab antimicrobial peptide tachystatin B with an inhibitory cystine-knot motif. J. Pept. Sci. 2007;13:269–279. doi: 10.1002/psc.846. [DOI] [PubMed] [Google Scholar]
- 37.Rodríguez A.A., Salceda E., Garateix A.G., Zaharenko A.J., Peigneur S., López O., Pons T., Richardson M., Díaz M., Hernández Y., et al. A novel sea anemone peptide that inhibits acid-sensing ion channels. Peptides. 2014;53:3–12. doi: 10.1016/j.peptides.2013.06.003. [DOI] [PubMed] [Google Scholar]
- 38.Olivera B.M., Hillyard D.R., Marsh M., Yoshikami D. Combinatorial peptide libraries in drug design: Lessons from venomous cone snails. Trends Biotechnol. 1995;13:422–426. doi: 10.1016/S0167-7799(00)88996-9. [DOI] [PubMed] [Google Scholar]
- 39.Sollod B.L., Wilson D., Zhaxybayeva O., Gogarten J.P., Drinkwater R., King G.F. Were arachnids the first to use combinatorial peptide libraries? Peptides. 2005;26:131–139. doi: 10.1016/j.peptides.2004.07.016. [DOI] [PubMed] [Google Scholar]
- 40.Ackerman S.E., Currier N.V., Bergen J.M., Cochran J.R. Cystine-knot peptides: Emerging tools for cancer imaging and therapy. Expert Rev. Proteomics. 2014;11:561–572. doi: 10.1586/14789450.2014.932251. [DOI] [PubMed] [Google Scholar]
- 41.Werle M., Schmitz T., Huang H.L., Wentzel A., Kolmar H., Bernkop-Schnürch A. The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery. J. Drug Target. 2006;14:137–146. doi: 10.1080/10611860600648254. [DOI] [PubMed] [Google Scholar]
- 42.Werle M., Kafedjiiski K., Kolmar H., Bernkop-Schnürch A. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration. Int. J. Pharm. 2007;332:72–79. doi: 10.1016/j.ijpharm.2006.09.028. [DOI] [PubMed] [Google Scholar]
- 43.Wiener S. Observations on the venom of the Sydney funnel-web spider (Atrax robustus) Med. J. Aust. 1961;48:693–699. [PubMed] [Google Scholar]
- 44.Sheumack D.D., Claassens R., Howden M.E.H., Whitley N.M. Complete amino acid sequence of of a new type of lethal neurotoxin from the venom of the funnel-web spider Atrax robustus. FEBS Lett. 1985;181:154–156. doi: 10.1016/0014-5793(85)81132-7. [DOI] [PubMed] [Google Scholar]
- 45.Fletcher J.I., Chapman B.E., Mackay J.P., Howden M.E.H., King G.F. The structure of versutoxin (δ-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel. Structure. 1997;5:1525–1535. doi: 10.1016/S0969-2126(97)00301-8. [DOI] [PubMed] [Google Scholar]
- 46.Pallaghy P.K., Alewood D., Alewood P.F., Norton R.S. Solution structure of robustoxin, the lethal neurotoxin from the funnel-web spider Atrax robustus. FEBS Lett. 1997;419:191–196. doi: 10.1016/S0014-5793(97)01452-X. [DOI] [PubMed] [Google Scholar]
- 47.Nicholson G.M., Little M.J., Tyler M., Narahashi T. Selective alteration of sodium channel gating by Australian funnel-web spider toxins. Toxicon. 1996;34:1443–1453. doi: 10.1016/S0041-0101(96)00089-X. [DOI] [PubMed] [Google Scholar]
- 48.Hale J.E., Butler J.P., Gelfanova V., You J.S., Knierman M.D. A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis. Anal. Biochem. 2004;333:174–181. doi: 10.1016/j.ab.2004.04.013. [DOI] [PubMed] [Google Scholar]